PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR)
today announced its ProBeam 360° proton therapy system is now
available in a multi-room configuration. The ProBeam 360° system is
the smallest multi-room system available for sale and offers
uncompromised clinical capabilities with up to a 30 percent smaller
footprint than the company's previous multi-room solution.
The ProBeam 360° system in a multi-room configuration allows
cancer centers to tailor the system to meet their clinical,
research, and capacity needs. Treatment room options include
360-degree rotating gantries, and fixed beam rooms. Research rooms
are also available to satisfy a variety of non-clinical proton beam
applications. In addition to the smaller footprint, the multi-room
ProBeam 360° system occupies up to 50 percent less volume, reducing
vault construction costs by approximately 25 percent.
The ProBeam 360° system features the most powerful particle
accelerator available today to treat cancer, a 360-degree gantry
for clinical efficiency, and iterative cone-beam CT imaging and
high-definition pencil-beam scanning for exceptional precision. The
system can also provide clinicians a viable path to potential
next-generation treatments such as FLASH therapy*.
"The multi-room configuration of ProBeam 360° system provides
clinics the flexibility to meet their treatment needs, while also
increasing access for patients to proton therapy," said
Kolleen Kennedy, chief growth
officer and president of Proton Therapy Solutions, Varian.
"Increasing access to advanced treatments like proton therapy is an
important step towards achieving our vision of a world without fear
of cancer."
For more information on ProBeam 360°, visit
www.varian.com/probeam360.
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries keep
the patient and our clinical partners at the center of our thinking
as we power new victories in cancer care. Because, for cancer
patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
*FLASH therapy is under preclinical research. It is not
available for clinical use and there is no guarantee of future
commercialization.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-announces-multi-room-configuration-for-probeam-360-proton-therapy-system-300918350.html
SOURCE Varian